Efficient revascularization by VEGF administration via heparin-functionalized nanoparticle-fibrin complex.
暂无分享,去创建一个
Young Ha Kim | Giyoong Tae | S. Yuk | Su-Jin Park | G. Tae | Kyoung-Oh Cho | Su-Jin Park | Soon Hong Yuk | Youn-Kyung Lee | Yong-Il Chung | Sang-Ki Kim | Youn-Kyung Lee | Kyoung-Oh Cho | Yong-Il Chung | Sang-Ki Kim
[1] A. Hoffman,et al. PEG-cross-linked heparin is an affinity hydrogel for sustained release of vascular endothelial growth factor , 2006, Journal of biomaterials science. Polymer edition.
[2] W. Saltzman,et al. Controlled delivery of VEGF via modulation of alginate microparticle ionic crosslinking. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[3] Wayne R. Gombotz,et al. Calcium-alginate beads for the oral delivery of transforming growth factor-β1 (TGF-β1): stabilization of TGF-β1 by the addition of polyacrylic acid within acid-treated beads , 1994 .
[4] T. Arakawa,et al. Stoichiometry of heparin binding to basic fibroblast growth factor. , 1994, Archives of biochemistry and biophysics.
[5] K. Plate,et al. Vascular endothelial growth factor , 1997, Journal of Neuro-Oncology.
[6] Roche ResearchCenter,et al. Vascular Permeability Factor: A Tumor-derived Polypeptide that Induces Endothelial Cell and Monocyte Procoagulant Activity, and Promotes Monocyte Migration , 1990 .
[7] J. Isner,et al. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. , 1998, The American journal of pathology.
[8] S. Epstein,et al. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. , 1996, Circulation.
[9] W. Risau,et al. Mechanisms of angiogenesis , 1997, Nature.
[10] S. Epstein,et al. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. , 1994, Circulation.
[11] Martin Ehrbar,et al. Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[12] A. G. Ding,et al. Rescue of SCID murine ischemic hindlimbs with pH-modified rhbFGF/poly(DL-lactic-co-glycolic acid) implants. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[13] Chad Johnson,et al. The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis. , 2004, Biomaterials.
[14] M. J. Santander-Ortega,et al. Colloidal stability of pluronic F68-coated PLGA nanoparticles: a variety of stabilisation mechanisms. , 2006, Journal of colloid and interface science.
[15] H. Dvorak,et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.
[16] Jun Ho Kim,et al. Asymmetrically porous PLGA/Pluronic F127 membrane for effective guided bone regeneration , 2006, Journal of biomaterials science. Polymer edition.
[17] Didier Letourneur,et al. Low Molecular Weight Fucoidan Increases VEGF165-induced Endothelial Cell Migration by Enhancing VEGF165 Binding to VEGFR-2 and NRP1* , 2006, Journal of Biological Chemistry.
[18] A. Kawada,et al. Alginate oligosaccharides stimulate VEGF-mediated growth and migration of human endothelial cells , 1999, Archives of Dermatological Research.
[19] K. Takaoka,et al. Heparin Potentiates the in Vivo Ectopic Bone Formation Induced by Bone Morphogenetic Protein-2* , 2006, Journal of Biological Chemistry.
[20] D. Rifkin,et al. Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation , 1988, The Journal of cell biology.
[21] P. Vaupel,et al. Therapeutic angiogenesis. , 1993, Archives of surgery.
[22] B. Lévy,et al. Vascular Endothelial Growth Factor‐B Promotes In Vivo Angiogenesis , 2003, Circulation research.
[23] G. Tae,et al. A facile method to prepare heparin-functionalized nanoparticles for controlled release of growth factors. , 2006, Biomaterials.
[24] Young Ha Kim,et al. Accelerated Micellization and Aggregation of Pluronic Micelles by Interaction with Heparin , 2010, Journal of biomaterials science. Polymer edition.
[25] J. Pearlman,et al. Vascular endothelial growth factor administration in chronic myocardial ischemia. , 1996, The American journal of physiology.
[26] Glenn D Prestwich,et al. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor. , 2005, Biomaterials.
[27] D. Connolly,et al. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration , 1990, The Journal of experimental medicine.
[28] J. Feijen,et al. Release of model proteins and basic fibroblast growth factor from in situ forming degradable dextran hydrogels. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[29] K. Thomas. Vascular Endothelial Growth Factor, a Potent and Selective Angiogenic Agent (*) , 1996, The Journal of Biological Chemistry.
[30] E. Brogi,et al. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. , 1994, The Journal of clinical investigation.
[31] S. Oh,et al. Fabrication and characterization of hydrophilized porous PLGA nerve guide conduits by a modified immersion precipitation method. , 2007, Journal of biomedical materials research. Part A.
[32] Giyoong Tae,et al. The effect of heparin on the gellation of Pluronic F-127 hydrogel , 2006 .
[33] E. Bauer,et al. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells , 1992, Journal of cellular physiology.